Bioengineered nisin derivatives with enhanced activity in complex matrices.
about
Bioengineering Lantibiotics for Therapeutic SuccessBioengineering of the model lantibiotic nisinBioengineered nisin A derivatives with enhanced activity against both Gram positive and Gram negative pathogensA bioengineered nisin derivative to control biofilms of Staphylococcus pseudintermediusIn vivo activity of nisin A and nisin V against Listeria monocytogenes in mice.Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity.Biomedical applications of nisin.Saturation mutagenesis of selected residues of the α-peptide of the lantibiotic lacticin 3147 yields a derivative with enhanced antimicrobial activity'Bac' to the future: bioengineering lantibiotics for designer purposes.Bacteriocins and bacteriophage; a narrow-minded approach to food and gut microbiology.Bacteriocin-Producing Lactic Acid Bacteria Isolated from Mangrove Forests in Southern Thailand as Potential Bio-Control Agents: Purification and Characterization of Bacteriocin Produced by Lactococcus lactis subsp. lactis KT2W2L.Bioengineering: a bacteriocin perspective.A Bioengineered Nisin Derivative, M21A, in Combination with Food Grade Additives Eradicates Biofilms of Listeria monocytogenesIntensive mutagenesis of the nisin hinge leads to the rational design of enhanced derivatives.Promoting acid resistance and nisin yield of Lactococcus lactis F44 by genetically increasing D-Asp amidation level inside cell wall.Bacteriocins as food preservatives: Challenges and emerging horizons.Fighting biofilms with lantibiotics and other groups of bacteriocins.
P2860
Q26774123-BE949A42-3D5E-4C7A-A77C-EDCD499C9C79Q28087616-A416549F-B5D0-49BF-A719-26AB5E08FFC9Q28484253-BEF1782E-8F23-4D0E-8021-B255BC51E2D9Q28544703-48A15A8F-9C96-403E-B233-7364210D100BQ34572089-431A87C3-AAF2-4926-95F0-AF859804000CQ34625915-87AD32F3-18BA-4C41-B593-7AF91AF0F46FQ36900890-087CA430-4609-4E25-99AA-19A7CE882952Q37569003-D3A3DF9C-2A28-43FF-8F59-E256ED5651CDQ38062005-2F33D591-0D46-4220-8643-66A13E1B88C9Q40084231-C0ED80DF-3D37-4FFF-A5F1-1842441FC2DEQ40090935-EA961201-B3F5-456E-9D5A-15DCC8F9482FQ41476222-B6BF951B-DAFD-4EB2-9230-E382ED8C9D58Q42362011-E04DE3C6-8A68-413C-B2DF-61FF0181CF12Q42735899-F66A5D99-795D-445C-91FF-49F4323380B2Q47992678-5F21C642-58E9-4F60-B805-82D08AEADB07Q48667972-F6B40F6D-4B8D-448C-B521-E02C0F7EA9A3Q55223927-02522BC5-F23B-42A3-A092-1D208D3757A9
P2860
Bioengineered nisin derivatives with enhanced activity in complex matrices.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Bioengineered nisin derivatives with enhanced activity in complex matrices.
@en
Bioengineered nisin derivatives with enhanced activity in complex matrices.
@nl
type
label
Bioengineered nisin derivatives with enhanced activity in complex matrices.
@en
Bioengineered nisin derivatives with enhanced activity in complex matrices.
@nl
prefLabel
Bioengineered nisin derivatives with enhanced activity in complex matrices.
@en
Bioengineered nisin derivatives with enhanced activity in complex matrices.
@nl
P2093
P2860
P50
P1476
Bioengineered nisin derivatives with enhanced activity in complex matrices.
@en
P2093
Karen M Daly
Paula M O'Connor
R Paul Ross
Susan Rouse
P2860
P304
P356
10.1111/J.1751-7915.2011.00324.X
P577
2012-01-20T00:00:00Z